Acupuncture for Chemical Therapy Induced Nausea and Vomiting

July 20, 2016 updated by: Yutong Fei, Beijing University of Chinese Medicine

Impact of Acupuncturist Expertise on Clinical Effectiveness for Chemotherapy Induced Nausea and Vomiting in Cancer Patients: a Randomized Controlled Trial

This is an expertise-based randomized controlled trial. The hypothesis of this study is that the differences in expertise of acupuncturist may impact clinical effect. In this study, patients will be randomized to 4 group, receiving the treatment from senior acupuncturist, junior acupuncturist, junior acupuncturist by only acupuncture Neiguan(P6), or not receive the acupuncture. All patients receive the basic cisplatin chemotherapy. The duration of treatment is from the first day receiving cisplatin until two days after cisplatin on each group. NCI and Rhode scale will be used to measure the control of nausea and vomiting.

Study Overview

Detailed Description

This is an expertise-based randomized controlled trial. The hypothesis of this study is that the differences in expertise of acupuncturist may impact clinical effect. In this study, 102 patients will be randomly divided into 4 groups which separately receiving the treatment from senior acupuncturist(clinical experience> 15 years, considered in this trial as highly expertised), junior acupuncturist(clinical experience< 5 years, considered in this trial as lower expertised), junior acupuncturist only acupuncture Neiguan(P6), or not receiving the acupuncture. All participants receive the cisplatin-based chemotherapy and 5-HT3 as antiemetic treatment will be included. Acupuncture treatments are given once daily, the duration of treatment is from the first day receiving cisplatin until two days after cisplatin. NCI and Rhode scale will be used to measure the control of nausea and vomiting. only outcome assessors are blinded. Generalized estimating equations will be used to compare the effects among groups.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China, 100091
        • Xiyuan Hospital, China Academy of Chinese Medical Sciences
    • Beijing
      • Beijing, Beijing, China, 100007
        • Dongzhimen Hospital, Beijing University of Chinese Medicine
      • Beijing, Beijing, China, 100053
        • Guanganmen Hospital,China Academy of Chinese Medical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Confirmed diagnosis of cancer
  • Must receive cancer chemotherapy containing cisplatin
  • Use 5-TH receptor antagonists as an antiemetic drug in the chemotherapy duration

Exclusion Criteria:

  • Concurrent neoplasms or illness that induces nausea independent of chemotherapy
  • Received acupuncture treatments for other conditions less than 4 weeks before chemotherapy treatment
  • Severe infection
  • Severe heart, liver, kidney and brain diseases
  • Cardiac pacemaker
  • Radiotherapy or hormone therapy during chemotherapy treatments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: A(senior acupuncturists)
Manual acupuncture implemented by senior acupuncturists (clinical experience >15 years)
Manual acupuncture once per day. No limitation on points, manipulations and time per session. Senior acupuncturists have to have more than 15 years of acupuncture clinical practice experience.
Other Names:
  • Traditional manual acupuncture
  • Traditional acupuncture
Active Comparator: B(junior acupuncturists)
Manual acupuncture implemented by junior acupuncturists (clinical experience <5 years)
Manual acupuncture once per day. No limitation on points, manipulations and time per session. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.
Other Names:
  • Traditional manual acupuncture
  • Traditional acupuncture
Active Comparator: C(P6 points)
Manual acupuncture on P6 points by junior acupuncturists (clinical experience <5 years)
Manual acupuncture implemented by junior acupuncturists once per day. P6 point, bilaterally, should achieve deqi sensation by even manipulations. Junior acupuncturists have to have less than 5 years of acupuncture clinical practice experience.
Other Names:
  • Traditional manual acupuncture
  • Traditional acupuncture
No Intervention: D(no acupuncture)
No acupuncture treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
NCI nausea and vomiting rating scale
Time Frame: From the first day receiving cisplatin until two days after cisplatin in each group
From the first day receiving cisplatin until two days after cisplatin in each group
Rhodes Scale
Time Frame: From the first day receiving cisplatin until two days after cisplatin in each group
From the first day receiving cisplatin until two days after cisplatin in each group

Secondary Outcome Measures

Outcome Measure
Time Frame
Global assessment on effectiveness by patients (a single direct question with five levels of alternatives)
Time Frame: The second day after cisplatin
The second day after cisplatin
Patients' confidence towards acupuncture treatment (a single direct question with five levels of alternatives)
Time Frame: The first day receiving cisplatin and the second day after cisplatin
The first day receiving cisplatin and the second day after cisplatin
Consumption of additional antiemetic
Time Frame: From the first day receiving cisplatin until two days after cisplatin
From the first day receiving cisplatin until two days after cisplatin

Other Outcome Measures

Outcome Measure
Time Frame
Acupuncture related adverse events
Time Frame: From the first day receiving cisplatin until two days after cisplatin
From the first day receiving cisplatin until two days after cisplatin
Adverse events
Time Frame: From the first day receiving cisplatin until two days after cisplatin
From the first day receiving cisplatin until two days after cisplatin

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

July 16, 2016

First Submitted That Met QC Criteria

July 20, 2016

First Posted (Estimate)

July 22, 2016

Study Record Updates

Last Update Posted (Estimate)

July 22, 2016

Last Update Submitted That Met QC Criteria

July 20, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EBM@BUCM-2
  • 30901929 (Other Grant/Funding Number: National Natural Science)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chemotherapy-induced Nausea and Vomiting

Clinical Trials on Manual acupuncture implemented by senior acupuncturists

Subscribe